Gilead Up Over 5%, Best Performer in the S&P 500 So Far Today -- Data Talk
February 24 2020 - 11:11AM
Dow Jones News
Gilead Sciences, Inc. (GILD) is currently at $73.54, up $3.84 or
5.51%
-- Would be highest close since Oct. 18, 2018, when it closed at
$74.17
-- On pace for largest percent increase since Aug. 30, 2017,
when it rose 7.25%
-- Gilead is testing an antiviral drug called remdesivir as a
treatment for COVID-19. Trials are currently under way in China to
test the drug, though The Wall Street Journal reported on Feb. 18
that the company has had trouble recruiting patients
-- Currently up three of the past four days
-- Currently up two consecutive days; up 9.76% over this
period
-- Best two day stretch since the two days ending Aug. 31, 2017,
when it rose 10.52%
-- Up 16.36% month-to-date; on pace for best month since Jan.
2018, when it rose 16.97%
-- Up 13.17% year-to-date
-- Down 39.82% from its all-time closing high of $122.21 on June
23, 2015
-- Would be a new 52-week closing high
-- Up 19.34% from its 52-week closing low of $61.62 on Oct. 2,
2019
-- Traded as high as $74.52; highest intraday level since Oct.
19, 2018, when it hit $74.80
-- Up 6.92% at today's intraday high; largest intraday percent
increase since Feb. 3, 2020, when it rose as much as 8.67%
-- Best performer in the S&P 500 today
-- Best performer in the Nasdaq 100 today
All data as of 10:34:39 AM
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
February 24, 2020 10:56 ET (15:56 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Aug 2024 to Sep 2024
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Sep 2023 to Sep 2024